ReviewBritish journal of clinical pharmacology2019
Antibiotic allergy labels in hospitalized and critically ill adults: A review of current impacts of inaccurate labelling.
Review in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 44 citations in OpenAlex.
- Clinical Outcome Associated With Beta-Lactam Allergy Labels in Hospitalized Patients in Belgium.Clinical and translational allergy · 2026Article
- Impact Assessment of the Allergy Fact Checker, a Clinical Decision Support Tool for Noninvasive Beta-Lactam Antibiotic Allergy Label Delabeling: Protocol for a Multicenter Crossover Cluster-Controlled Study.JMIR research protocols · 2026Article
- PEN-FAST in pediatrics: a reliable tool for penicillin allergy assessment?European journal of pediatrics · 2025Article
- Efficacy and Value of Antibiotic Allergy Evaluations in a Pediatric Solid Organ Transplant Population.Open forum infectious diseases · 2025Article
- Evaluation of Antibiotic Allergy in the Ambulatory Setting Using a Standardized Questionnaire.Journal of pharmacy practice · 2024Article
- Article
- Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics.Drug safety · 2024Article
- Outcomes of acute pyelonephritis in patients with a penicillin allergy label in the United States.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024Article
- A Comprehensive Review of Sulfonamide Hypersensitivity: Implications for Clinical Practice.Clinical reviews in allergy & immunology · 2023Review
- Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial.Pilot and feasibility studies · 2023Article
- A potential cost savings analysis of a penicillin de-labeling program.Frontiers in allergy · 2023Article
- Approach for delabeling beta-lactam allergy in children.Frontiers in allergy · 2023Review
- Penicillin Allergy Label Is Associated With Worse Clinical Outcomes in Bacterial Pneumonia.The journal of allergy and clinical immunology. In practice · 2022Article
- Article
- Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.The journal of allergy and clinical immunology. In practice · 2022Article
- Beta-lactam allergy labeling in intensive care units: An observational, retrospective study.Medicine · 2021Observational
- Focus group study exploring the issues and the solutions to incorrect penicillin allergy-labelled patients: an antibiotic stewardship patient safety initiative.European journal of hospital pharmacy : science and practice · 2021Article
- Reported β-Lactam and Other Antibiotic Allergies in Solid Organ and Hematopoietic Cell Transplant Recipients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Antibiotic allergy labels in hospitalized and critically ill adults: A review of current impacts of inaccurate labelling.British journal of clinical pharmacology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic allergy labels (AALs) are reported by approximately 20% of hospitalized patients, yet over 85% will be negative on formal allergy testing. Hospitalized patients with an AAL have inferior patient outcomes, increased colonization with multidrug-resistant organisms and frequently receive inappropriate antimicrobials. Hospitalized populations have been well studied but, to date, the impact of AALs on patients with critical illness remains less well defined. We review the prevalence and impact of AALs on hospitalized patients, including those in in critical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.